Recent news on Hydroxychloroquine

No tears to shed: The dry eye disease  -  May 8, 2007
Daily Mail,Hydroxychloroquine, traditionally an anti-malaria pill, was prescribed to help her pains. Then there was Biotene to help replace the saliva,

Toddler to set the pace at Medina Arthritis Walk  -  May 3, 2007
Akron Beacon Journal,...and intravenous immunoglobulin); immunosuppressants (methotrexate, azathioprine); anti-inflammatory drugs (hydroxychloroquine); and exercise therapy.

Oral Lichen Planus Responds to Methotrexate, Pimecrolimus  -  Apr 18, 2007
Medscape (subscription)2 to 3 times daily, alternating with clobetasol; (4) hydroxychloroquine, 200 mg orally twice daily; (5) retinoid, including isotretinoin, 80 mg/day,

Combination Drug Therapy Retards Early RA Damage  -  Mar 20, 2007
MedPage Today,Methotrexate, followed by methotrexate with sulfasalazine, methotrexate with sulfasalazine and hydroxychloroquine, methotrexate with sulfasalazine,

The BeSt Way to Treat Early Rheumatoid Arthritis?  -  Mar 19, 2007
Annals of Internal MedicineTreatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med.

Increasing options available for malaria prophylaxis in children  -  Feb 1, 2007
AAP News (subscription)Egypt and some countries in the Middle East), chloroquine phosphate or hydroxychloroquine sulfate remain the drugs of choice for chemoprophylaxis.

A Stain in Time  -  Jan 3, 2007
New England Journal of Medicine (subscription),The patient's physicians made a diagnosis of seronegative lupus and started treatment with hydroxychloroquine. The chest pain had resolved and the joint

Arthritis Clinical Trial Results Revealed  -  Jan 2, 2007
Journal of American Medical Association (subscription),...drugs that suppress the immune and/or inflammatory systems, including methotrexate, sulfasalazine, hydroxychloroquine, leflunomide, and cyclosporine.

For RA Cardioprotection, Biologics Found Equal to Methotrexate  -  Nov 29, 2006
MedPage Today,The noncytotoxic agents, which included gold, Plaquenil (hydroxychloroquine) and Azulfidine (sulfasalazine), did not significantly increase cardiovascular ...

Prevalence of conventional and lupus-specific risk factors for ...  -  Dec 2, 2006
HeartZine,...controls, CVD patients were more likely to have lupus anticoagulant (P = 0.03), but less likely to be receiving treatment with hydroxychloroquine (P = 0.003). ...

Cytotoxic and Glucocorticoid Agents Increase CV Risk in Rheumatoid ...  -  Nov 29, 2006
Medscape (subscription)...or infliximab), anakinra, cytotoxic agents (azathioprine, cyclosporine, leflunomide), noncytotoxic agents (gold, hydroxychloroquine, sulfasalazine), and ...

Travel to Malaria-Endemic Areas Requires a Mosquito Map  Nov 8, 2006
Aralen or Plaquenil (hydroxychloroquine sulfate) has been used continuously for years by travelers but can cause retinal toxicity after five to six years of ... -MedPage Today, Publicado: Sab Oct 14, 2006 5:01 pm Asunto: Unless directed to do ...  Oct 14, 2006
...in school. Atte hydroquinone tion Deficit Disorder, better known as ADD, is becoming quite wel hydroxychloroquine known. Probably ... -Shell Security, Rheumatoid arthritis does not increase risk of hearing loss  Sep 1, 2006
The researchers also noted a possible link between the hearing loss and rheumatoid arthritis medications, as patients who took Hydroxychloroquine were somewhat ... -Xagena.it

After 40 years waiting, glimmer of light at end of tunnel for SLE ...  Sep 15, 2006
...“Anti-malarial drugs are commonly used, particularly Plaquenil (hydroxychloroquine sulfate), which is marketed by Sanofi-Aventis.�. ... -PipelineReview.com

Health Checkup: new treatments for rheumatoid arthritis  Sep 13, 2006
It has traditionally included the disease-modifying antirheumatic drugs hydroxychloroquine, sulfasalazine and methotrexate, and the more recent leflunomide. ... -Rochester Democrat and Chronicle

Former Chiron Exec Joins APT Pharmaceuticals as CEO  Sep 6, 2006
APT's lead program is examining the potential of inhaled hydroxychloroquine (HCQ), a disease-modifying antirheumatic drug (DMARD) as a steroid-alternative ... -Business Wire

Aradigm Announces the Results of the AERx HCQ Asthma Phase 2a Study  -  Nov 21, 2006
PipelineReview.com (press release),Today announced that the results of the Phase 2a clinical trial program of inhaled hydroxychloroquine (HCQ) as treatment for patients with

Prevalence of conventional and lupus-specific risk factors for ...  -  Dec 2, 2006
HeartZine,CVD patients were more likely to have lupus anticoagulant (P = 0.03), but less likely to be receiving treatment with hydroxychloroquine (P = 0.003).

Cytotoxic and Glucocorticoid Agents Increase CV Risk in Rheumatoid ...  -  Nov 29, 2006
Medscape (subscription)...cytotoxic agents (azathioprine, cyclosporine, leflunomide), noncytotoxic agents (gold, hydroxychloroquine, sulfasalazine), and glucocorticoids.

For RA Cardioprotection, Biologics Found Equal to Methotrexate  -  Nov 29, 2006
MedPage Today,The noncytotoxic agents, which included gold, Plaquenil (hydroxychloroquine) and Azulfidine (sulfasalazine), did not significantly increase cardiovascular

My arthritis is so bad that every step's agony - but it won't stop ...  -  Nov 21, 2006
Daily Mail - UK,I started taking hydroxychloroquine sulphate, to suppress my immune system, and Meloxicam, a strong anti-inflammatory. That worked quite well and the

Enbrel Provides Sustained Clinical Improvements for People With ...  -  Nov 20, 2006
DG NewsPatients taking hydroxychloroquine, sulfasalazine, methotrexate, or prednisone (≤ 10 mg/day) could continue these drugs at stable doses for the duration of

Aradigm Announces the Results of the AERx HCQ Asthma Phase 2a Study  -  Nov 20, 2006
Genetic Engineering News (press release),Aradigm Corporation (PINKSHEETS: ARDM) today announced that the results of the Phase 2a clinical trial program of inhaled hydroxychloroquine (HCQ) as

Aradigm Announces the Results of the AERx HCQ Asthma Phase 2a Study  -  Nov 20, 2006
Market Wire (press release)...that the results of the Phase 2a clinical trial program of inhaled hydroxychloroquine (HCQ) as treatment for patients with moderate-persistent asthma,

Data Shows ENBREL Provides Sustained Clinical Improvements For ...  -  Nov 15, 2006
Medical News Today (press release),Patients taking hydroxychloroquine, sulfasalazine, methotrexate, or prednisone (less than or equal to 10 mg/day) could continue these drugs at stable doses

Antimalarials Effective Against Thrombosis in Patients With ...  Jun 29, 2006
Antimalarials such as chloroquine and hydroxychloroquine have been shown to have beneficial effects in patients with SLE, an effect that appears to be mediated ... -DG News

Combination DMARD Therapy Produces Sustained Remission in Early RA ...  Jun 27, 2006
These patient were randomised to receive either a combination of traditional DMARDs (MTX, sulfasalazine [SSZ] and hydroxychloroquine [HCQ], with prednisolone ... -DG News



Aradigm Reports First Quarter 2006 Financial Results and Corporate ...  May 15, 2006
...the company and its partner, APT Pharmaceuticals, announced the initiation of a Phase 2 clinical trial investigating aerosolized hydroxychloroquine (HCQ) as an ... - Market Wire

Ethnic Skin: A Spectrum of Issues  Apr 19, 2006
...are also an option. Oral antibiotics for their anti-inflammatory effects or oral hydroxychloroquine are often used. In some cases ... - Medscape (subscription)





Steroid treatment for arthritis ups pneumonia risk  Mar 16, 2006
...report in the medical journal Arthritis & Rheumatism that the most common treatments were methotrexate, prednisone, Remicade, hydroxychloroquine and Enbrel. ... - Reuters.uk

Aradigm begins midstage trial for asthma  Mar 23, 2006
The trial will study the safety and efficacy of an aerosolized formulation of hydroxychloroquine using Hayward-based Aradaigm's(NASDAQ: ARDM) pulmonary ... - East Bay Business Times

Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program ...  Mar 23, 2006
...a privately held biotechnology company, today announced the initiation of their Phase 2 clinical trial investigating aerosolized hydroxychloroquine (HCQ) as an ... - Market Wire

Ciphergen CFO quits, shares fall  Mar 23, 2006
...based APT Pharmaceuticals Inc., a privately held biotechnology company, began the second phase of clinical trial for aerosolized hydroxychloroquine, as an anti ... - San Jose Mercury News

APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 ...  Mar 21, 2006
The company is developing steroid-alternative therapies based on targeted administration of hydroxychloroquine (HCQ), a disease modifying antirheumatic drug ... - Genetic Engineering News

Arthritis drug that may help the worst cases  Mar 20, 2006
The tendency is to use the heavier treatment early: in the first instance, gold compounds, hydroxychloroquine, or sulfasalazin (better known to patients with ... - Times Online

Immune system attacks body in lupus  Mar 23, 2006
...prednisone (steroids), or other drugs that suppress the overactive immune system such as cyclophosphamide, methotrexate, hydroxychloroquine and intravenous ... - The Daily Athenaeum Interactive

Aradigm and APT move asthma treatment into phase II  Mar 24, 2006
...and APT Pharmaceuticals, a privately held biotechnology company, have initiated a phase II clinical trial investigating aerosolized hydroxychloroquine, or HCQ ... - Pharmaceutical Business Review

Rheumatoid Arthritis Does Not Increase Risk Of Hearing Loss, Mayo ...  Mar 8, 2006
The researchers also noted a possible link between the hearing loss and rheumatoid arthritis medications, as patients who took hydroxychloroquine were somewhat ... - Medical News Today



Arthritis Blog Archives  07 Mar 2006
Another possible connection may exist between hearing loss and some arthritis medications such as Plaquenil (hydroxychloroquine). - About - News & Issues,

Plaquenil for Alopecia Areata, Alopecia Totalis  Feb 18, 2006
1. Coexisting significant systemic disease that would increase risk of hydroxychloroquine (eg renal disease, liver disease, alcoholism, anemia, blood dyscrasia ... - Community Dispatch

Parental Magico-Religious Illness Beliefs in an Adolescent Girl ...  Jan 23, 2006
...rash and arthritis. The treatment, with a favorable outcome, consisted of hydroxychloroquine and prednisone, 10 mg/day. When she ... - Psychosomatics (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional